Trademark Search in Canada

TALFREZAN

View On IC.GC.CA

REGISTERED

on 18 Jul 2019

Last Applicant/ Owned by

JOHNSON & JOHNSON

One Johnson & Johnson PlazaNew Brunswick, NJ 08933-7001

Serial Number

1868453 filed on 17^th Nov 2017

Registration Number

TMA1042766 registered on 18^th Jul 2019

Registration expiry Date

18^th Jul 2029

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

K1P1C3

TALFREZAN

Trademark usage description

human pharmaceuticals for the prevention or treatment of auto-immune diseases, cardiovascular diseases, pulmonary hypertension, pulmonary arterial hyp Read More

Classification Information

Class [005]
Human pharmaceuticals for the prevention or treatment of auto-immune diseases, cardiovascular diseases, pulmonary hypertension, pulmonary arterial hypertension, gastro-intestinal diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, cerebrovascular diseases and digital ulcers; pharmaceutical preparations for the prevention or treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; pharmaceutical preparations for the prevention or treatment of neurological diseases, namely Alzheimer's, Huntington's disease, cerebral palsy and peripheral neurological system diseases; pharmaceutical preparations for the prevention or treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia; anxiolytic medications; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases and psoriasis; anti-viral medications; anti-inflammatory medications; anti-pain medications; anti-infective medications; anti-allergic medications; human vaccines

Classification kind code

Mark Details

Serial Number

1868453

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 190 on 10^th Jul 2019	Registration Pending
Submitted for opposition 191 on 10^th Jul 2019	Registration Fee Notice Sent
Submitted for opposition 42 on 17^th Apr 2019	Advertised
Submitted for opposition 26 on 28^th Mar 2019	Approved
Submitted for opposition 27 on 8^th Feb 2019	Approval Notice Sent
Submitted for opposition 22 on 7^th Jan 2019	Search Recorded
Submitted for opposition 20 on 7^th Jan 2019	Examiner's First Report
Submitted for opposition 31 on 23^rd Nov 2017	Formalized
Submitted for opposition 30 on 17^th Nov 2017	Filed
Submitted for opposition 1 on 17^th Nov 2017	Created